Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Thiazolidine; Pim kinase inhibitor.
Coccidiostat, GAPDH inhibitor.
Cholesterol ester transfer protein inhibitor.
Calcitonin-family peptide, involved in vasodila...
FAK inhibitor.
PDE5 inhibitor.
Atypical amino acid found in Isaria sinclairi, ...
Peptide; NK2 antagonist.
Recombinant HIV glycoprotein antigen fragment.<...
Ras inhibitor.
Diarylether; bacterial ENR binder, fatty acid s...
Taxane found in species of Taxus; potential mic...
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Natural antibiotic found in Streptomyces parvul...
Analog of staurosporine.
Fluoroquinolone; vacuolar H+ ATPase, topoisomer...
Nucleoside (deoxyadenosine) analog found in Co...
Endogenous peptide fragment, involved in vasoco...
Shellfish toxin produced by dinoflagellates and...
Thienylbutyl ITC analog.